WATCH HERE: Mukesh Ambani speech on Reliance Jio at AGM today

Mukesh Ambani, chairman of Reliance Jio will make a ‘significant announcement’ about the 4G wireless service provider’s offerings at 11 AM on Friday while delivering his annual speech at its parent’s annual general meeting. A live webcast of Mukesh Ambani’s speech at the AGM, at which he is expected to announce the launch of ultra-cheap […]

Pakistan Army protests cross-border attacks by India

Pakistan’s Director General of Military Operations protested Indian attacks on the Line of Control in Kashmir in a meeting with his Indian counterpart. According to a statement released by the Indian side, Pakistan complained that Indian Army had killed four Pakistani soldiers and one civilian by cross-border firing. India and Pakistan are engaged in a […]

Reliance Capital receives Rs 378 cr from Nippon Life for AMC stake

Anil Ambani Group’s Reliance Capital said it received Rs. 378 crore from Nippon Life Insurance, one of the largest life insurers in the world, after the foreign company increased its stake in Reliance Nippon Life Asset Management Limited to 49%. The original agreement to increase the stake from 26% to 49% was announced on March […]

Demonetization took India forward by 3 years – SBI

The demonetization of currency notes late last year has doubled the number of card transactions and helped push India’s payment digitisation by three years, State Bank of India said in a note. “Even after seven months post demonetization, the transaction value is quite large and approximately double of what it had been corresponding month last […]

Mahindra launches fuel-efficient van under Jeeto brand to take on Maruti Suzuki Omni

Automaker Mahindra & Mahindra launched a new minivan based on its Jeeto platform, priced at Rs 3.45 lakh before taxes. At the price, the van is likely to appeal to semi-commercial users, such as schools, institutions and shops. The company already has a similar offering on its Maxximo platform, priced at Rs 3.05 lakh. The […]

RELIANCE JIO unveils NEW PLANS valid from today

India’s biggest wireless data provider Reliance Jio unveiled a new set of plans as it continues to migrate its customers towards paid plans. The key difference between the new plans and the previous Dhan Dhana Dhan offer is that the new plans offer double validity for the recharges, while the earlier plan offered triple validity. […]

GMR closes funding for Mopa Airport, Axis Bank underwrites debt

GMR Goa International Airports Limited said it closed funding for the upcoming Mopa Airport in Goa, with Axis Bank underwriting the entire debt of Rs 1,330 cr. “Having tied up funding for the project, we are working towards starting on ground construction activity post monsoon,” said Srinivas Bommidal, chairman of GMR Airports. “We are confident […]

Glenmark gets US FDA approval for generic version of Daiichi Sankyo’s hypertension drug

Glenmark Pharmaceuticals said it got approval from US authorities to launch a generic version of Daiichi Sankyo’s hypertension drug Azor in various dosages. The drug had annual sales of approximately $211.6 million as of May. The approval was obtained from United States Food & Drug Administration for Amlodipine and Olmesartan Medoxomil tablets in dosages ranging […]

Jubilant Life Sciences gets USFDA nod for anti-depressant

Jubilant Life Sciences said it received final approval from US authorities to launch a generic version of Valeant’s anti-depressant Wellbutrin. The approval from FDA is for introducing Bupropion Hydrochloride tablets in 150 mg and 300 mg doses. The drug is used for the treatment of major depressive disorder and prevention of seasonal affective disorder. “This […]

Lupin launches eye drug in the US

Pharma company Lupin said it launched Moxifloxacin Hydrochloride eye solution in the US. Lupin’s Moxifloxacin Hydrochloride Ophthalmic solution USP, 0.5% (base), is an AT1 rated generic equivalent of Novartis Pharms Corp.’s Vigamox Ophthalmic solution. It is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the organisms. Vigamox Ophthalmic solution had US […]

Zydus Cadila starts Phase II trial on anemia drug for kidney patients

Zydus said it started phase II trial on its anemia drug candidate ZYAN1. The drug, a hypoxia-inducible factor prolyl hydroxylase inhibitor, is being tested as a treatment for anemia associated with chronic kidney disease (CKD). The move follows successful Phase 1 trials. A drug has to go through three phases of clinical trials before it […]

Exit mobile version